Needham Reiterates Buy on Merit Medical Systems, Maintains $101 Price Target
Needham analyst Mike Matson reiterates Merit Medical Systems (NASDAQ:MMSI) with a Buy and maintains $101 price target.
Stocks · News reference
8-K filing — MERIT MEDICAL SYSTEMS INC (MMSI)
Filed: 2026-08-20 AccNo: 0000856982-26-000047 Size: 4 MB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Brinker International To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday
Top analysts changed outlook on top names. Truist, Morgan Stanley, B of A Securities, HC Wainwright, Baird, and Stephens & Co. altered price targets for various stocks.
B of A Securities Maintains Neutral on Merit Medical Systems, Raises Price Target to $97
B of A Securities analyst Craig Bijou maintains Merit Medical Systems (NASDAQ:MMSI) with a Neutral and raises the price target from $92 to $97.